Last updated on March 2020

A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant


Brief description of study

The purpose of this study is to evaluate conversion rate to minimal residual disease (MRD) negativity following the addition of daratumumab to lenalidomide relative to lenalidomide alone, when administered as maintenance treatment to anti-cluster of differentiation 38 (CD38) treatment naive participants with newly diagnosed multiple myeloma who are MRD positive as determined by next generation sequencing (NGS) following high-dose therapy (HDT) and autologous stem cell transplant (ASCT), with or without consolidation therapy.

Clinical Study Identifier: NCT03901963

Find a site near you

Start Over

Yale University Medical Center

New Haven, CT United States
  Connect »

Miami Cancer Institute

Miami, FL United States
  Connect »

Moffitt Cancer Center

Tampa, FL United States
  Connect »

Cleveland Clinic Florida

Weston, FL United States
  Connect »

Franciscan Health

Indianapolis, IN United States
  Connect »

Norton Cancer Institute

Louisville, KY United States
  Connect »

Ochsner Clinic Foundation

New Orleans, LA United States
  Connect »

Henry Ford Cancer Institute

Detroit, MI United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Sarah Cannon Cancer Institute

Kansas City, MO United States
  Connect »

Washington University

Saint Louis, MO United States
  Connect »

Northwell Health

Lake Success, NY United States
  Connect »

University of North Carolina

Chapel Hill, NC United States
  Connect »

Wake Forest Health Sciences

Winston-Salem, NC United States
  Connect »

Thomas Jefferson University

Philadelphia, PA United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Huntsman Cancer Institute

Salt Lake City, UT United States
  Connect »

University of Washington

Seattle, WA United States
  Connect »

Cancer Care Northwest

Spokane, WA United States
  Connect »

NYU Winthrop

Mineola, NY United States
  Connect »

Baptist Cancer Center

Memphis, TN United States
  Connect »

Novant Oncology Research Institute

Winston-Salem, NC United States
  Connect »

West Penn Hospital

Pittsburgh, PA United States
  Connect »

Tennessee Oncology

Chattanooga, TN United States
  Connect »

University of Colorado Health

Fort Collins, CO United States
  Connect »

Novant Health

Charlotte, NC United States
  Connect »

Tennessee Oncology

Nashville, TN United States
  Connect »